{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:24:01Z","timestamp":1788355441531,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["11\/100\/34"],"award-info":[{"award-number":["11\/100\/34"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019434","name":"NIHR Exeter Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eclinm.2022.101819","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:31:21Z","timestamp":1673483481000},"page":"101819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-1733","authenticated-orcid":false,"given":"Dominic","family":"Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Buckland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Picton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-9569","authenticated-orcid":false,"given":"Raj","family":"Thuraisingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Borrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stoves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mysore","family":"Phanish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Yee","family":"Shiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimun","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqar","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Tinch-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bidad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fenur","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McCrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-2518","authenticated-orcid":false,"given":"Janet","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dorling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eclinm.2022.101819_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"issue":"Suppl 7","key":"10.1016\/j.eclinm.2022.101819_bib2","first-page":"138","article-title":"Measures of care in adult renal transplant recipients in the United Kingdom (chapter 11)","volume":"22","author":"Ravanan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"4 Suppl 1","key":"10.1016\/j.eclinm.2022.101819_bib3","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US renal data system 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101819_bib4","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101819_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.eclinm.2022.101819_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfy077","article-title":"Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review","volume":"33","author":"Sharma","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101819_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002572","article-title":"Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: a systematic review and meta-analysis","volume":"15","author":"Bouquegneau","year":"2018","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.eclinm.2022.101819_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101819_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.kint.2016.10.009","article-title":"Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells","volume":"91","author":"Shiu","year":"2017","journal-title":"Kidney Int"},{"issue":"79","key":"10.1016\/j.eclinm.2022.101819_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2020.00079","article-title":"Effect of optimized immunosuppression (including rituximab) on anti-donor alloresponses in patients with chronically rejecting renal allografts","volume":"11","author":"Shiu","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101819_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00007890-200107150-00016","article-title":"Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection","volume":"72","author":"Theruvath","year":"2001","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.eclinm.2022.101819_bib12","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.eclinm.2022.101819_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.tp.0000220480.84449.71","article-title":"Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial","volume":"81","author":"Meier","year":"2006","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.eclinm.2022.101819_bib14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/TP.0b013e3182130966","article-title":"Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the Transept Switch study","volume":"91","author":"Meier-Kriesche","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101819_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6215-15-30","article-title":"Can a combined screening\/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial","volume":"15","author":"Dorling","year":"2014","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101819_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13063-019-3602-2","volume":"20","author":"Stringer","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.eclinm.2022.101819_bib17","article-title":"Sample size adaptations in a randomised controlled biomarker based strategy (hybrid) trial: experience from the OUTSMART trial","volume":"18","author":"Stringer","year":"2017","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101819_bib18","first-page":"746","article-title":"An introduction to multiplicity issues in clinical trials: the what, why, when and how","volume":"46","author":"Li","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eclinm.2022.101819_bib19","series-title":"Measuring mental health needs","first-page":"200","article-title":"Costing psychiatric interventions","author":"Beecham","year":"2001"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101819_bib20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101819_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J\u00a0Psychosom Res"},{"issue":"4","key":"10.1016\/j.eclinm.2022.101819_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101819_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A\u00a0randomized trial of bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101819_bib24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.2020071106","article-title":"A\u00a0randomized clinical trial of anti-IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection","volume":"32","author":"Doberer","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101819_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14728214.2022.2091131","article-title":"Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials","volume":"27","author":"Mayer","year":"2022","journal-title":"Expet Opin Emerg Drugs"},{"issue":"3","key":"10.1016\/j.eclinm.2022.101819_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ki.2015.100","article-title":"B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection","volume":"88","author":"Shiu","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.eclinm.2022.101819_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/tri.13126","article-title":"The possible critical role of T-cell help in DSA-mediated graft loss","volume":"31","author":"Susal","year":"2018","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101819_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.01.033","article-title":"Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence","volume":"96","author":"Cherukuri","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.eclinm.2022.101819_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.eclinm.2022.101819_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/tri.12864","article-title":"Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation","volume":"30","author":"Caillard","year":"2017","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.eclinm.2022.101819_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ki.2010.556","article-title":"Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection","volume":"79","author":"Kimball","year":"2011","journal-title":"Kidney Int"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702200548X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702200548X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:18:32Z","timestamp":1762899512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702200548X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":31,"alternative-id":["S258953702200548X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101819","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101819"}}